SARS-CoV-2 peptide epitopes presented by Human Leukocyte Antigen class II (HLA class II) (SARS-CoV-2 HLA-II epitopes)

SARS-CoV-2 peptide epitopes presented by HLA class II molecules are short amino acid sequences derived from viral proteins that are displayed on the surface of antigen-presenting cells. These complexes are formed when viral proteins, such as Spike (S), Nucleocapsid (N), or Membrane (M), are proteolytically processed and loaded onto Human Leukocyte Antigen (HLA) class II molecules like HLA-DR, HLA-DQ, or HLA-DP (Grifoni et al., 2020, Cell). The primary biological function of these epitopes is to serve as the recognition signal for CD4+ T helper cells, which are essential for coordinating the adaptive immune response (Mateus et al., 2020, Science). Recognition by the T-cell receptor (TCR) triggers CD4+ T cell activation, leading to the secretion of pro-inflammatory cytokines and the provision of help to B cells for high-affinity antibody production (Tarke et al., 2021, Cell Reports Medicine). In the context of COVID-19, these epitopes are critical for establishing long-term cellular memory and protection against severe disease. Therapeutic strategies targeting these epitopes include the development of multi-peptide vaccines, such as CoVac-1, which aim to induce broad and potent T-cell responses independent of neutralizing antibodies (Heitmann et al., 2022, Nature). Additionally, these epitopes are used as biomarkers in diagnostic assays like ELISpot to monitor vaccine efficacy and natural immunity.

Other names

SARS-CoV-2 CD4+ T cell epitopesSARS-CoV-2 MHC class II epitopesHLA-restricted SARS-CoV-2 peptidesSARS-CoV-2 T-cell epitopes

Recognition by CD4+ T-cell receptors (TCRs) on T helper cells, which triggers T-cell activation, cytokine secretion, and coordination of B-cell and CD8+ T-cell responses.